...
首页> 外文期刊>The biochemical journal >The conversion of human complement component C5 into fragment C5b by the alternative-pathway C5 convertase
【24h】

The conversion of human complement component C5 into fragment C5b by the alternative-pathway C5 convertase

机译:通过替代途径C5转化酶将人补体组分C5转化为片段C5b

获取原文
           

摘要

pThe cleavage of human complement component C5 to fragment C5b by the alternative pathway C5 convertase was studied. The alternative-pathway C5 convertase on zymosan can be represented by the empirical formula zymosan--C3b2BbP. Both properdin-stabilized C3 and C5 convertase activities decay with a half life of 34 min correlating with the loss of the Bb subunit. The C5 convertase functions in a stepwise fashion: first, C5 binds to C3b and this is followed by cleavage of C5 to C5b. The capacity to bind C3b is a stable feature of component C5, as C5b also has this binding capacity. Component C5, unlike component C3, does not form covalent bonds with zymosan after activation, and C5 is not inhibited by amines. Therefore C5, although similar in structure to C3, does not appear to contain the internal thioester group reported for C3 and C4./p
机译:研究了通过替代途径C5转化酶将人补体组分C5切割成片段C5b。 zymosan上的替代途径C5转化酶可以用经验公式zymosan–C3b2BbP表示。备解素稳定的C3和C5转化酶活性都以34分钟的半衰期衰减,这与Bb亚基的丢失有关。 C5转化酶以逐步的方式起作用:首先,C5与C3b结合,然后将C5裂解为C5b。结合C3b的能力是组分C5的稳定特征,因为C5b也具有该结合能力。不同于组分C3,组分C5在活化后不与酵母聚糖形成共价键,并且C5不受胺的抑制。因此,C5虽然结构与C3相似,但似乎没有报告C3和C4的内部硫酯基。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号